Literature DB >> 11113862

Increased expression of tissue inhibitor of metalloproteinases type 1 (TIMP-1) in a more tumourigenic colon cancer cell line.

R E Hewitt1, K E Brown, M Corcoran, W G Stetler-Stevenson.   

Abstract

Genetic changes occurring in the late stages of colonic tumour progression have received much less attention than those occurring in the early stages. As described in the accompanying paper, SW480 and SW620 cell lines provide a useful model for studying the advanced stages of progression for colon cancer. Comparison of the two cell lines by differential display reveals that SW620 cells express lower levels of the CC3 tumour suppressor gene and also lower levels of the tissue inhibitor of metalloproteinases-3 (TIMP-3) gene. Northern blot analysis for TIMP-3 confirms this finding and shows a similar difference in the expression of TIMP-2, which seems logical since TIMPs inhibit enzymes that play a role in tumour invasion. For this reason, it was surprising to find that TIMP-1 messenger RNA expression is markedly increased in SW620 cells. Consistent with this finding, western blot analysis shows a ten-fold increase in TIMP-1 protein secretion by SW620 cells. It is noteworthy that high TIMP-1 expression is associated with poor prognosis in colorectal cancer. This association between TIMP-1 expression and tumour progression may be related to additional growth factor-like effects described for TIMP-1 in some systems. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113862     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH777>3.0.CO;2-E

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  Effective treatment of advanced colorectal cancer by rapamycin and 5-FU/oxaliplatin monitored by TIMP-1.

Authors:  Markus Wagner; Vincent Roh; Michael Strehlen; Alexander Laemmle; Deborah Stroka; Bernhard Egger; Markus Trochsler; Kelly K Hunt; Daniel Candinas; Stephan A Vorburger
Journal:  J Gastrointest Surg       Date:  2009-06-30       Impact factor: 3.452

2.  Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer.

Authors:  Dao-Hai Zhang; Lee Lee Wong; Lee Kian Tai; Evelyn S C Koay; Robert E Hewitt
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

3.  Proliferation-inhibiting and apoptosis-inducing effects of ursolic acid and oleanolic acid on multi-drug resistance cancer cells in vitro.

Authors:  Jian-zhen Shan; Yan-yan Xuan; Shu-qin Ruan; Mei Sun
Journal:  Chin J Integr Med       Date:  2011-08-09       Impact factor: 1.978

4.  Silencing of Wnt5a during colon cancer metastasis involves histone modifications.

Authors:  Qian Li; Hong Chen
Journal:  Epigenetics       Date:  2012-06-01       Impact factor: 4.528

5.  The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.

Authors:  Barbara Mroczko; Magdalena Groblewska; Bogna Okulczyk; Bogusław Kedra; Maciej Szmitkowski
Journal:  Int J Colorectal Dis       Date:  2010-06-17       Impact factor: 2.571

Review 6.  Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS).

Authors:  Marta Lukaszewicz-Zając; Barbara Mroczko; Johannes Kornhuber; Piotr Lewczuk
Journal:  J Neural Transm (Vienna)       Date:  2013-12-24       Impact factor: 3.575

7.  Decreased TIP30 expression promotes tumor metastasis in lung cancer.

Authors:  Xin Tong; Kai Li; Zhigang Luo; Bin Lu; Xing Liu; Tao Wang; Mingshu Pang; Beibei Liang; Min Tan; Mengchao Wu; Jian Zhao; Yajun Guo
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

8.  Contribution of TIP30 to chemoresistance in laryngeal carcinoma.

Authors:  M Zhu; F Yin; L Yang; S Chen; R Chen; X Zhou; W Jing; X Fan; R Jia; H Wang; H Zheng; J Zhao; Y Guo
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

9.  Model selection and efficiency testing for normalization of cDNA microarray data.

Authors:  Matthias Futschik; Toni Crompton
Journal:  Genome Biol       Date:  2004-07-30       Impact factor: 13.583

10.  The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib.

Authors:  Wen-Quan Wang; Liang Liu; Hua-Xiang Xu; Hui-Chuan Sun; Chun-Tao Wu; Xiao-Dong Zhu; Wei Zhang; Jin Xu; Chen Liu; Jiang Long; Quan-Xing Ni; Zhao-You Tang; Xian-Jun Yu
Journal:  Oncotarget       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.